Bridgend, UK – 18 September 2025: A new book titled “Transforming the Pharmaceutical Supply Chain” by Hedley Rees, published in September 2025, delves into deep-rooted
United States FDA Introduces a New Initiative Readers may be familiar with the words of FDAs Janet Woodcock, MD, in the early 2000s, calling for:
In Part 1, we concluded that 21st Century cGMP faces critical challenges, given four-decades of strategic realignment of industry business models. Readers wishing to recap
What is cGMP for the 21st Century? As many reading this will know, cGMP, stands for current Good Manufacturing Practice. It is the quality management
What is medicinal product (drug) repurposing? Repurposing a medicinal product (drug or biologic) involves gaining a licence for an already approved, non-patented product, in different
Who would argue that we don’t need innovation in biopharmaceuticals? Some are even calling for disruptive innovation, to tackle the thorny issues of affordability and